Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 388

1.

Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.

Schlößer HA, Drebber U, Kloth M, Thelen M, Rothschild SI, Haase S, Garcia-Marquez M, Wennhold K, Berlth F, Urbanski A, Alakus H, Schauss A, Shimabukuro-Vornhagen A, Theurich S, Warnecke-Ebertz U, Stippel DL, Zippelius A, Büttner R, Hallek M, Hölscher AH, Zander T, Mönig SP, von Bergwelt-Baildon M.

Oncoimmunology. 2015 Nov 9;5(5):e1100789. doi: 10.1080/2162402X.2015.1100789. eCollection 2016 May.

PMID:
27467911
2.

[New S3 guideline for esophageal cancer : Important surgical aspects].

Hölscher AH, Stahl M, Messmann H, Stuschke M, Meyer HJ, Porschen R.

Chirurg. 2016 Jul 12. [Epub ahead of print] German.

PMID:
27406251
3.

Gastric Outlet Obstruction After Esophagectomy: Retrospective Analysis of the Effectiveness and Safety of Postoperative Endoscopic Pyloric Dilatation.

Maus MK, Leers J, Herbold T, Bludau M, Chon SH, Kleinert R, Hescheler DA, Bollschweiler E, Hölscher AH, Schäfer H, Alakus H.

World J Surg. 2016 May 23. [Epub ahead of print]

PMID:
27216809
4.

Management of Tracheo- or Bronchoesophageal Fistula After Ivor-Lewis Esophagectomy.

Lambertz R, Hölscher AH, Bludau M, Leers JM, Gutschow C, Schröder W.

World J Surg. 2016 Jul;40(7):1680-7. doi: 10.1007/s00268-016-3470-9.

PMID:
26913731
5.

The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.

Becker J, May A, Gerges C, Anders M, Schmidt C, Veits L, Noder T, Mayershofer R, Kreuser N, Manner H, Venerito M, Hofer JH, Lyros O, Ahlbrand CJ, Arras M, Hofer S, Heinrichs SK, Weise K, Hess T, Böhmer AC, Kosiol N, Kiesslich R, Izbicki JR, Hölscher AH, Bollschweiler E, Malfertheiner P, Lang H, Moehler M, Lorenz D, Ott K, Schmidt T, Nöthen MM, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismüller J, Knapp M, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J.

Cancer Med. 2016 May;5(5):888-91. doi: 10.1002/cam4.641. Epub 2016 Jan 18.

6.

Embedding a Virtual Patient Simulator in an Interactive Surgical lecture.

Kleinert R, Plum P, Heiermann N, Wahba R, Chang DH, Hölscher AH, Stippel DL.

J Surg Educ. 2016 May-Jun;73(3):433-41. doi: 10.1016/j.jsurg.2015.11.006. Epub 2015 Dec 15.

PMID:
26705061
7.

Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.

Schlößer HA, Drebber U, Urbanski A, Haase S, Baltin C, Berlth F, Neiß S, von Bergwelt-Baildon M, Fetzner UK, Warnecke-Eberz U, Bollschweiler E, Hölscher AH, Mönig SP, Alakus H.

Gastric Cancer. 2015 Dec 7. [Epub ahead of print]

PMID:
26643879
8.

Diagnostic marker signature for esophageal cancer from transcriptome analysis.

Warnecke-Eberz U, Metzger R, Hölscher AH, Drebber U, Bollschweiler E.

Tumour Biol. 2016 May;37(5):6349-58. doi: 10.1007/s13277-015-4400-4. Epub 2015 Dec 2.

PMID:
26631031
9.

International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.

Nafteux PR, Lerut AM, Moons J, Hölscher AH, Bollschweiler E, Henegouwen MI, Lagarde SM, van Lanschot JJ, Messager M, Mariette C, D'Journo XB, Thomas PA, De Leyn PR.

Ann Surg. 2015 Nov;262(5):809-15; discussion 815-6. doi: 10.1097/SLA.0000000000001463.

PMID:
26583670
10.

Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.

Becker J, May A, Gerges C, Anders M, Veits L, Weise K, Czamara D, Lyros O, Manner H, Terheggen G, Venerito M, Noder T, Mayershofer R, Hofer JH, Karch HW, Ahlbrand CJ, Arras M, Hofer S, Mangold E, Heilmann-Heimbach S, Heinrichs SK, Hess T, Kiesslich R, Izbicki JR, Hölscher AH, Bollschweiler E, Malfertheiner P, Lang H, Moehler M, Lorenz D, Müller-Myhsok B, Ott K, Schmidt T, Whiteman DC, Vaughan TL, Nöthen MM, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismüller J, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J.

Cancer Med. 2015 Nov;4(11):1700-4. doi: 10.1002/cam4.500. Epub 2015 Aug 15.

11.

Preoperative airway colonization prior to transthoracic esophagectomy predicts postoperative pulmonary complications.

Bludau M, Hölscher AH, Bollschweiler E, Leers JM, Gutschow CA, Brinkmann S, Schröder W.

Langenbecks Arch Surg. 2015 Aug;400(6):707-14. doi: 10.1007/s00423-015-1326-7. Epub 2015 Aug 8.

PMID:
26252998
12.
13.

Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment.

Bollschweiler E, Hölscher AH, Schmidt M, Warnecke-Eberz U.

Chin J Cancer Res. 2015 Jun;27(3):221-30. doi: 10.3978/j.issn.1000-9604.2015.04.04. Review.

14.

Design, Realization, and First Validation of an Immersive Web-Based Virtual Patient Simulator for Training Clinical Decisions in Surgery.

Kleinert R, Heiermann N, Wahba R, Chang DH, Hölscher AH, Stippel DL.

J Surg Educ. 2015 Nov-Dec;72(6):1131-8. doi: 10.1016/j.jsurg.2015.05.009. Epub 2015 Jun 19.

PMID:
26094909
15.

Molecular markers predicting lymph node metastasis in early esophageal cancer.

Plum PS, Warnecke-Eberz U, Dhaouadi O, Alakus H, Drebber U, Metzger R, Prenzel KL, Hölscher AH, Bollschweiler E.

Histol Histopathol. 2015 Oct;30(10):1193-202. doi: 10.14670/HH-11-618. Epub 2015 Apr 14.

PMID:
25869644
16.

The epidemiology, diagnosis, and treatment of Barrett's carcinoma.

Labenz J, Koop H, Tannapfel A, Kiesslich R, Hölscher AH.

Dtsch Arztebl Int. 2015 Mar 27;112(13):224-33; quiz 234. doi: 10.3238/arztebl.2015.0224. Review.

17.

3D immersive patient simulators and their impact on learning success: a thematic review.

Kleinert R, Wahba R, Chang DH, Plum P, Hölscher AH, Stippel DL.

J Med Internet Res. 2015 Apr 8;17(4):e91. doi: 10.2196/jmir.3492. Review.

18.

Prognostic impact of blood biomarkers TS and DPD in neoadjuvant-treated esophageal cancer patients.

Grimminger PP, Maus MK, Bergenthal J, Wandhöfer C, Fetzner UK, Herbold T, Bollschweiler E, Hölscher AH, Brabender J.

Anticancer Res. 2015 Mar;35(3):1297-302.

PMID:
25750278
19.

Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.

Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.

Tumour Biol. 2015 Jun;36(6):4643-53. doi: 10.1007/s13277-015-3112-0. Epub 2015 Jan 29.

PMID:
25631748
20.

Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?

Fuchs H, Hölscher AH, Leers J, Bludau M, Brinkmann S, Schröder W, Alakus H, Mönig S, Gutschow CA.

Gastric Cancer. 2016 Jan;19(1):312-7. doi: 10.1007/s10120-015-0466-3. Epub 2015 Jan 28.

PMID:
25627475
Items per page

Supplemental Content

Loading ...
Write to the Help Desk